Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 -38.83M
March 31, 2026 -44.15M
December 31, 2025 -32.92M
September 30, 2025 -26.09M
June 30, 2025 -4.23M
March 31, 2025 -23.58M
December 31, 2024 -0.072M
September 30, 2024 -19.69M
June 30, 2024 -0.414M
March 31, 2024 -26.65M
December 31, 2023 -3.417M
September 30, 2023 -0.054M
June 30, 2023 0.029M
March 31, 2023 -18.90M
December 31, 2022 -1.014M
September 30, 2022 -0.069M
June 30, 2022 -23.00M
March 31, 2022 0.00
December 31, 2021 -0.05M
September 30, 2021 -2.242M
June 30, 2021 -6.782M
March 31, 2021 -3.00M
December 31, 2020 -23.68M
September 30, 2020 -8.492M
June 30, 2020 0.025M
Date Value
March 31, 2020 -5.992M
December 31, 2019 -2.319M
September 30, 2019 -0.189M
June 30, 2019 -14.83M
March 31, 2019 -2.23M
December 31, 2018 0.00
September 30, 2018 -21.56M
June 30, 2018 -4.319M
March 31, 2018 -5.328M
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 9.522M
March 31, 2017 -15.53M
December 31, 2016 -1.73M
September 30, 2016 -11.63M
June 30, 2016 -0.48M
March 31, 2016 -20.28M
December 31, 2015 0.00
September 30, 2015 -0.229M
June 30, 2015 -5.296M
March 31, 2015 -42.23M
December 31, 2014 -10.70M
September 30, 2014 -0.576M
June 30, 2014 -0.023M
March 31, 2014 -14.72M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Savara, Inc. -0.189M
Lite Strategy, Inc. 1.792M
AbbVie, Inc. 9.00M
Marker Therapeutics, Inc. 0.00
Rezolute, Inc. -0.747M